LivaNova to shelve mitral heart valve device programme in restructuring
Share:
(Reuters) - LivaNova Plc said on Wednesday it would stop developing its minimally-invasive mitral heart valve device and restructure its heart valve unit after years of declining sales. The company is racing with firms such as Medtronic Plc to launch the first transcatheter mitral valve replacement (TMVR) device that can help patients avoid traditional open-heart surgeries through the use of a catheter or tube to replace the valve. The soonest a replacement programme will hit the market is at..